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Following the intricate architecture of the eukaryotic cell, protein synthesis involves formation of
many macromolecular assemblies, some of which are composed by tRNA-aminoacylation enzymes.
Protein–protein and protein–tRNA interactions in these complexes can be facilitated by non-cata-
lytic tRNA-binding proteins. This review focuses on the dissection of the molecular, structural and
functional properties of a particular family of such proteins: yeast Arc1p and its homologues in pro-
karyotes and higher eukaryotes. They represent paradigms of the strategies employed for the orga-
nization of sophisticated and dynamic nanostructures supporting spatio-temporal cellular
organization.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The central dogma of molecular biology states that the genetic
information is encoded in DNA, transcribed to mRNA and ﬁnally
translated to protein [1]. While complementarity is enough to
drive transcription, charged tRNAs are the key molecules bridging
the worlds of nucleic acids and proteins. After years of research,
the biochemistry of protein synthesis is becoming deﬁnite and de-
ﬁned in terms of the factors involved, but the cell biology of tRNA
synthesis and function still adds new pieces into the jigsaw: in the
traditional view, pre-tRNA transcripts originating in the nucleus
are subsequently processed at their 50 and 30 termini, decorated
with several nucleotide modiﬁcations and, for intron-containing
tRNA species, spliced before the mature molecules are exported
to the cytoplasm, where they are charged with the appropriate
amino acid and participate in protein synthesis [2]. However
according to recent advances, tRNA aminoacylation occurs also inchemical Societies. Published by E
e; NLS, nuclear localization
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and tRNA transport is not unidirectional but can include nuclear
export, retrograde nuclear import and nuclear re-export (see re-
cent review [3]).
Along its travels tRNA encounters and interacts with processing,
modiﬁcation and aminoacylation enzymes as well as transport and
translation factors that guide it through the cellular compartments
and onto the ribosome. Apart of these proteins, tRNAs are often es-
corted by tRNA-binding proteins, which perform no apparent cata-
lytic function but can be involved in the formation of multi-enzyme
complexes [4]. A well-characterized prototype of these proteins,
yeast Arc1p, is the subject of this review. It will be examined to-
gether with its homologues in prokaryotes, such as Trbp111, or
higher eukaryotes, such as p43 (pro-EMAPII), p38 and p18. Non-
catalytic appended domains of aminoacyl-tRNA synthetases
(aaRSs), that are evolutionary and functionally linked to Arc1p
and its orthologues, have been the main subject of recent reviews
[5,6] and will be, therefore, only brieﬂymentionedwhen necessary.
2. Arc1p mediates the formation of a multi-synthetase complex
in lower eukaryotes
Arc1p (its name being derived from aaRS cofactor 1) was orig-
inally identiﬁed in 1996 as the product of a yeast gene, mutations
in which caused synthetic lethality when combined withlsevier B.V. All rights reserved.
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a nuclear-pore associated protein involved in tRNA biogenesis [8]
but was subsequently shown to be the yeast tRNA exportin medi-
ating transport of tRNAs from the nucleus to the cytoplasm [9].
Afﬁnity puriﬁcation of Arc1p revealed its tight association with
two proteins identiﬁed as yeast cytosolic MetRS and GluRS [7].
This was the ﬁrst demonstration of a multi-aaRS complex in
unicellular eukaryotes. Higher multi-cellular eukaryotes were al-
ready known to contain a much larger multi-enzyme complex
comprising nine aaRSs (including MetRS and GluRS) and three
non-catalytic proteins, p18, p38 and p43 [10]. The formation of this
complex was thought to be mediated by the non-catalytic ap-
pended domains of the aaRSs, which were characteristic of the
eukaryotic enzymes and absent from their prokaryotic homo-
logues. Afﬁnity puriﬁcations as well as in vitro binding studies
demonstrated that the yeast aaRS complex could only be formed
in the presence of Arc1p, which could associate simultaneously
with both MetRS and GluRS, while the enzymes could not directly
interact with each other [7,11].
3. The primary structure organization and homologies of Arc1p
Primary structure analysis of Arc1p revealed a basic polypep-
tide sequence of 376 residues, comprising three fairly distinguish-
able domains named N, M and C (Fig. 1) [7]. The N-terminal (N)
domain (residues 1–131; Arc1-N) displayed at ﬁrst little homology
to other known proteins [7]. However, it was later shown to con-
tain a conserved sequence motif, originally identiﬁed in the bacte-
rial glutathione S-transferase (GST) super-family but, also present
in many other eukaryotic components of the translation machinery
including the N-terminal appended domains of many eukaryotic
GluRSs, mammalian MetRS, ValRS and CysRS, eukaryotic elonga-
tion factors eEF-1b and eEF-1c and the two non-catalytic compo-
nents of the mammalian multi-synthetase complex, p18 an p38
[5,12,13]. As described in detail below, this GST-like N-domain of
Arc1p was subsequently shown to be responsible for its interac-
tions with the corresponding domains in GluRS and MetRS
[11,12,14,15], suggesting a prototype mode of association that
was also later demonstrated for most of the other aaRS-containing
complexes [5].
The middle (M) domain of Arc1p stretches between residues
132 and 200 (Arc1-M), is very basic, rich in alanines and lysines
and shows sequence similarity to H1 histones [7]. As also discussed
below, it binds RNA non-speciﬁcally and can, thus, contribute to
the afﬁnity of Arc1p for tRNA [7,14]. Finally, the C-terminal (C) do-
main (residues 201–376; Arc1-C) is neutral and exhibits signiﬁcant
homology (54% identity) to the human protein EMAP II (endothe-
lial-monocyte-activating polypeptide II) [16], which was subse-
quently shown to represent a C-terminal proteolytic fragment of
the third non-catalytic component of the mammalian multi-syn-
thetase complex, p43 [17]. Similar homology was later also shown
to the C-terminal appendix of Caenorhabditis elegans and plant
MetRS [14,18] and human TyrRS [5,14].
The ﬁrst half of the C-domain of Arc1p (residues 202–306,
termed Arc1-C1 [12]) contains a distinct structural motif called
the OB-fold and is also homologous to the C-terminal appendix
of Escherichia coli MetRS, the N-terminal part of the b subunit of
E. coli PheRS [14] and, most importantly, to the core sequence of
the bacterial structure-speciﬁc tRNA-binding protein Trbp111
[19]. The OB fold is also part of the anticodon binding domain of
three unrelated aaRSs (AsnRS, AspRS, and LysRS). In contrast, the
second half of the C-domain (Arc1-C2, residues 307–376) has
homologies only among eukaryotic proteins. As described below,
the M and C parts of Arc1p constitute its tRNA-binding domain
(TRBD). Overall, Arc1p shares homologies with all the three non-catalytic components of the mammalian multi-synthetase complex
(p18, p38 and p43), probably reﬂecting a functional conservation
between the yeast and the mammalian complexes.
4. The tRNA binding properties of Arc1p
The original identiﬁcation of Arc1p as a protein genetically
linked to the tRNA transport pathway and its physical association
with two tRNA-aminoacylation enzymes probed experiments to
test its ability to interact with tRNA. Using electrophoretic mobility
shift assays, it was shown that recombinant Arc1p could bind to
in vitro transcribed yeast tRNAMet. This binding was competed by
other tRNAs while competition by either unstructured or highly
structured RNAmolecules other than tRNA (such as 5S rRNA) failed
to saturate the tRNA binding site of Arc1p suggesting speciﬁc inter-
action with the tRNA tertiary structure [7]. Furthermore, an accep-
tor minihelix (comprising TwC arm-acceptor stem), but not an
anticodon hairpin minihelix, partially challenged tRNA binding
and indicated that the conserved TwC loop should contribute to
the interaction [7]. Performing similar experiments with trunca-
tion mutants of Arc1p, made clear that the N-domain of Arc1p
was dispensable for tRNA binding. In contrast, both the M-domain
and the C-domain could individually interact with tRNA, albeit
with low afﬁnity. However, when the two domains were combined
(as in an Arc1-DN mutant) binding afﬁnity for tRNA was similar to
that of the full-length protein, which was calculated to correspond
to a Kd of approximately 10 nM [14]. Additional cross-linking and
gel retardation experiments [7,14] indeed suggested that a high
afﬁnity and speciﬁc tRNA-binding domain (TRBD) is formed in
Arc1p by its M-part (which provides non-speciﬁc RNA–protein
afﬁnity) and C-part (which provides tRNA-structure speciﬁcity),
in accordance also with the homologies described above. Overall,
these results predicted that the TRBD recognized the elbow of
the general L form of tRNA, formed by the D- and TwC-loops, where
conserved invariant bases are clustered, and left the anticodon arm
and the acceptor helix free for interactions with aminoacylation
enzymes.
When Arc1p was challenged with total yeast tRNA, it preferen-
tially bound to a small group of tRNAs, which included the ‘‘cog-
nate” tRNAs for the Arc1p-MetRS-GluRS complex (tRNAGlu and
tRNAMet), suggesting that Arc1p, in addition to its tRNA-structure
speciﬁcity, may also exhibit limited tRNA-species speciﬁcity [11]
and hinting that selective pressure rather than chance forced the
incorporation of MetRS and GluRS in the yeast and probably also
the mammalian complex. Analysis of the sequence of these tRNAs
revealed the presence of certain unique elements to this group,
including the C2–G71 and G51–C63 base pairs in the acceptor
arm, the G10–C25–G45 triad in the base of the anticodon stem
and C32 and G57 in the anticodon and TwC loops, respectively.
These nucleotides may act as positive determinants for the interac-
tion with Arc1p, a notion which has, however, never been con-
ﬁrmed experimentally (e.g., by foot-printing). The preference of
Arc1p for G–C elements may, nevertheless, explain its previous
identiﬁcation as a protein (termed G4p1) with afﬁnity for quadru-
plex (G4) nucleic acids, structures formed in vitro by nucleic acids
that contain guanine tracts [20].
5. The tRNA binding properties of Trbp111 and p43
5.1. Trbp111
The demonstration of the tRNA-binding function of Arc1p trig-
gered analogous studies in its TRBD-containing homologues in bac-
teria (Trbp111) and mammals (p43), for which also crystal
structure information became soon available. Trbp111 (tRNA
Fig. 1. Schematic representation of yeast Arc1p, its homologues in bacteria (Trbp111) and human (p18, p38 and p43) and their protein–protein interactions. Homologous
domains (roughly drawn in scale) are depicted in the same color and labeled (in, at least, one representative case) as follows: OB, OB-fold containing domain; TRBD, tRNA-
binding domain; GST-like, GST-like motif or structure containing domain; WHEP, helix-turn-helix non-speciﬁc RNA-binding motif containing domain; leu, leucine-zipper
(coiled-coil) motif containing domain; lys, lysine-rich domain; pseudo-OB, domain with a structure mimicking an OB-fold. The catalytic domains of the aaRSs are shown in
gray and are not drawn in scale. Colored double arrow-heads indicate well-characterized or mapped interactions while blank ones indicate poorly mapped, putative or
predicted interactions. For further details and references see text.
3844 E. Karanasios, G. Simos / FEBS Letters 584 (2010) 3842–3849binding protein 111) is a 111 amino acid long Aquifex aeolicus poly-
peptide, which corresponds to the C1 subdomain of Arc1p contain-
ing the OB fold, also homologous to several other bacterial proteins
and to parts of E. coli MetRS and PheRS. Recombinant Trbp111, a
dimer in solution, was shown by band-shift analysis to bind tRNAs
(with an apparent Kd of 32 nM) but not RNA duplexes, RNA hair-
pins, single-stranded RNA nor 5S rRNA, representing thus a struc-
ture-speciﬁc tRNA-binding protein [19]. Since A. aeolicus Trbp111has a comparable afﬁnity for tRNA as Arc1p but lacks the lysine-
rich M-domain of Arc1p (which contributes to its afﬁnity for tRNA),
it appears to have a higher speciﬁcity for the tRNA structure. Res-
olution of the crystal structure of Trbp111 and its E. coli homologue
conﬁrmed a dimeric organization and the presence of a classical OB
fold in each monomer [21]. Furthermore, extensive mutagenesis
analysis and construction of a docking model of the Trbp111-tRNA
complex [21] suggested that Trbp111 interacts with the outside
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allowing for asymmetrical docking of the convex side of tRNA to
the dimer. Subsequent foot-printing analysis conﬁrmed this model
[22] and also showed protection at several sites coinciding with or
close to the positions of the conserved elements in the tRNA spe-
cies that bound strongly to Arc1p (see above). Overall, the existing
data supported a similar mode of interaction with tRNA for both
Arc1p TRBD and Trbp111 with, however, a strong discrepancy:
Trbp111 bound to tRNA as a dimer but Arc1p as a monomer. This
discrepancy was resolved by structural data concerning the mam-
malian homologue of both proteins, p43.
5.2. p43
Cloning of the p43 cDNA in 1997 revealed both its identity to
the precursor of the human cytokine EMAPII and its homology to
Arc1p [17]. The human p43 is a 312 amino acid long proteins
which, as Arc1p, can be roughly divided in three domains
(Fig. 1): the N-terminal part (residues 1–110) which is basic and
very conserved among mammalian species but shows no distinct
homologies to proteins from other kingdoms, the middle part (res-
idues 110–146) which is more variable and highly charged con-
taining Lys and Glu stretches and the C-terminal part (residues
147–312) which corresponds to the mature EMAPII and is very
similar to the C-domain of Arc1p and its homologous proteins
mentioned above. This C-terminal part of p43 was tested in band
shift assays and shown to be able to bind to several yeast tRNA
transcripts but not to short RNA homopolymers suggesting that
it associates with tRNA molecules in a structure-speciﬁc manner
[17]. Its calculated afﬁnity for tRNA was quite low (Kd about
40 lM) compared to that of Arc1p TRBD, but this could be due to
the fact that the p43 C-terminal part tested lacked a sequence cor-
responding to the very basic M-domain of Arc1p. Indeed when full-
length p43 was tested [23], it exhibited substantially higher afﬁn-
ity for tRNA (Kd around 0.2 lV), a fact originally attributed to
synergistical contribution from the p43 N-terminal part (residues
1–146) which could also bind independently to tRNA (with a Kd
of 7.5 lV). Finally, a C-terminal fragment of p43 encompassing res-
idues 107–312, which is produced upon apoptosis (termed
p43ARF), exhibited the highest afﬁnity for tRNA (Kd around
6 nM) and was also able to bind with comparable strength (Kd:
11 nM) minihelices representing the acceptor-TwC stem loop do-
main of tRNA [24]. Therefore, as in Arc1p, the TRBD of p43 is bimo-
dal, that is, it is formed by combining a basic, lysine-rich part of the
protein (analogous to Arc1p-M) with the evolutionary conserved
C-terminal EMAPII-like domain and, as Trbp111, appears to recog-
nize the outside corner of the L-shaped tRNA.
Unlike Arc1p, however, crystal structural information for at
least part of the p43 TRBD became soon available [25,26]. The C-
terminal EMAPII-like domain of p43 was shown to adopt a mono-
meric compact structure comprising two tightly associated
subdomains of 100 and 60 amino acids, respectively. As expected
by the strong homologies, the N-terminal Trbp111-like (and
Arc1-C1-like) subdomain formed a characteristic OB fold. Surpris-
ingly, the C-terminal subdomain (the Arc1-C2-like), despite its
unrelated sequence, was shown to ‘‘mimic” a partial OB fold which
relates to the ‘‘genuine” N-terminal OB fold by a degenerate two-
fold symmetry and in the same manner as one monomer relates
to the second monomer in the symmetrical Trbp111 (or the closely
related CsaA) dimer [21,26,27]. Therefore, the interdomain inter-
face in the EMAPII-like p43 domain mimics the intersubunit inter-
face in Trbp111/CsaA and may thus generate a novel OB-fold-based
tRNA binding site. The topology of this domain may be the result of
convergent evolution, generated by the fusion of an ancestral
Trbp111/CsaA-like OB fold to an unrelated domain. Furthermore,
the fact that the pseudo-OB subdomain masks the region of theOB fold that is responsible for dimerization in Trbp111 and CsaA,
explains why both Arc1p and p43 TRBDs are monomers. Although
it remains unknown how tRNA docks onto these TRBDs, the struc-
tural ‘‘mimicry” exhibited by the p43 C-terminal domain suggests
that its tRNA-interaction mode may resemble the one in the
Trbp111-tRNA complex, bearing, of course in mind, the structurally
unknown but important – in terms of afﬁnity – contribution of the
polybasic N-terminal part of the TRBD.
6. The protein–protein interactions of Arc1p
Early truncation mutant analysis showed that the N-domain of
Arc1p (residues 1–131; Arc1-N) was necessary and sufﬁcient for
simultaneous interaction with both MetRS and GluRS, while the
synthetases were unable to form a complex in the absence of Arc1p
[7,11,14]. Both synthetases contain N-terminal extensions when
compared with the corresponding bacterial enzymes. In the case
of MetRS, it was long known that the 185 residue long N-terminal
domain (MetRS-N), which carried no homologies to known pro-
teins, could be removed without affecting its activity or stability
[28]. Its removal also inhibited binding of MetRS to Arc1p
in vitro [7] and in vivo [12], suggesting that it contained an Arc1p
binding site. Indeed, MetRS-N alone could readily associate with
Arc1p again both in vivo [12] and in vitro [29]. In the case of GluRS,
sequence analysis revealed an N-terminal extension of 210 amino
acids (GluRS-N), part of which (residues 87–170), as already men-
tioned, corresponded to a GST-like sequence also present in the N-
domain of Arc1p as well as other related proteins ([12], see also
above). Deletion of the sequence N-terminal to this GST-like motif
(residues 9–85), retained association of GluRS with Arc1p and Met-
RS while further deletions into this motif abolished complex
assembly [12]. In the converse experiment, deletion of the very
N-terminal part of Arc1p (residues 7–32) caused dissociation of
MetRS but not GluRS, while further deletions impaired binding of
both GluRS and MetRS, suggesting that the N-domain of Arc1p har-
bors distinct but possibly overlapping binding sites for the N-ter-
minal domains of MetRS and GluRS [12].
Binary (Arc1p/MetRS and Arc1p/GluRS) as well as ternary
(Arc1p/MetRS/GluRS) complexes could be readily formed in vitro
using individually puriﬁed recombinant proteins suggesting non-
synergistic complex assembly that involved no other proteins or
tRNA [11]. These data were later conﬁrmed in a quantitative man-
ner by surface plasmon resonance experiments [29]. In these as-
says Arc1p exhibited higher afﬁnity for the isolated N-terminal
domains of GluRS and MetRS (Kds 9 and 39 nM, respectively) than
the full length enzymes (Kds 39 and 193 nM, respectively), showing
that the catalytic domains of the synthetases do not participate in
complex assembly and they may even hinder it. Furthermore, pre-
formation of the binary Arc1p/GluRS complex did not substantially
increase the afﬁnity for MetRS and the results from simultaneous
binding of both GluRS and MetRS to Arc1p suggested the presence
of two independent interaction sites on Arc1p, both of which sup-
port a non-synergistic mode of association.
All the above biochemical data were substantiated by structural
studies involving the N-terminal interacting domains of all three
proteins and their respective binary complexes, which also led to
the construction of a model for the ternary complex [15,30,31].
Predictably for Arc1p and GluRS but unexpectedly for MetRS (be-
cause of the lack of homology), all three domains adopted a GST-
like fold. Complex formation between Arc1-N and MetRS-N
involved classical GST homo-dimerization while the heterodimer
between Arc1-N and GluRS-N was formed by a novel mode of
interaction [15]. Both interaction surfaces were of similar size,
but only half of the interaction surface of the classical E. coli GST
homodimer (1600 Å2 instead if 3200 Å2) [15]. According to the
structural data, the N-terminal domain of Arc1p contains two
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amino acid stretches 22–46 for MetRS and 52–61 and 92–121 for
GluRS [15]. The two enzymes bind to roughly opposite sides of
the Arc1p GST-like fold, which is shorter than the classical GST fold
(it lacks the N-terminal a/bmotif). In contrast, both subdomains of
the classical GST fold are conserved in the GluRS and MetRS N-ter-
mini. The Arc1p binding site on GluRS involves residues 122–131
and 157–173 while on MetRS it largely lies between residues 56
and 92. The models agree with and explain all previous biochemi-
cal data mapping the interaction sites with one possible exception.
Deletions in the C-terminus of Arc1p-N, which contains only the
binding site for GluRS, disrupted the interaction with both synthe-
tases [12]. However, the structure of Arc1-N predicts that these
deletions affected core elements of the GST-like fold and may have
caused extensive misfolding.
The crystal structures further showed that most of the residues
participating in the binary interactions were non-polar and com-
plex formation appeared to depend mainly on hydrophobic and
van der Waals forces between two complementary sets of interac-
tion surfaces [15]. This was validated by point-mutation analysis of
several conserved amino acid residues, aiming to increase the size
of the side chains and disrupt the complementarity of interaction
surfaces [29]. Mutations such as Arc1p(A26R) or Arc1p(T55R), Met-
RS(A63H) and GluRS(T125R), abolished complex formation [15,29],
but alternative point mutations of the same residues, such as
Arc1p(T55V) and GluRS(T125V) with milder effect to the interface
complementarity, reduced the afﬁnity between the components
but still allowed complex assembly [29]. Mutations abolishing
stacking interactions such as Arc1p(R100A) or Arc1p(Y104A),
GluRS(R164A) and MetRS(F59A) were detrimental for complex
assembly while mutations affecting possible hydrogen bonds or
salt bridges such Arc1p(S33A) or GluRS(K157A) were tolerated de-
spite their negative effects on afﬁnities [15,29]. Finally, in agree-
ment with all the binding studies, the ternary complex model
precluded any direct contact between the N-domains of the syn-
thetases or any signiﬁcant structural rearrangements upon com-
plex formation suggesting lack of synergy and indicating rigidity
of the domains that could undergo ‘‘plugging” interactions, the rate
and extent of which could be determined solely by diffusion rates
and afﬁnities [15].
7. The protein–protein interactions of p18, p38 and 43
The mode of interaction between Arc1p and the two yeast syn-
thetases may serve as prototype for other synthetase complexes,
especially the mammalian multi-synthetase complex, several com-
ponents of which contain GST-like domains. In fact, as the para-
digm of yeast MetRS-N dictates, GST-like structures may be more
widespread than primary sequence analysis simply predicts.
Intriguingly, however, the GST-like N-terminal domain of Arc1p
is not present in its closest human homologue, p43, but can be dis-
cerned in the other two non-catalytic components of the multi-
synthetase complex, p18 and p38, which contain no TRBD
(Fig. 1). This evolutionary splitting of the GST-like domain from
the TRBD is difﬁcult to understand but, signiﬁcantly, is paralleled
in all three human proteins by the acquisition of additional func-
tions that are unrelated to tRNA but relevant to the multi-cellular
nature of higher organisms (reviewed in [4,32]).
7.1. p18
Mammalian p18 is a conserved 174 amino acid long protein
[13] and the GST-like domain covers most of its length (Fig. 1).
Solution of the p18 crystal structure conﬁrmed the presence of
the GST-fold and predicted two potential binding sites [33], in
analogy with the model proposed for the interactions of the N-ter-minal domain of Arc1p [15]. Moreover, p18 has been reported to
interact with mammalian MetRS [34], the N-terminal appendix
of which is also predicted to adopt a GST-fold (Fig. 1) by sequence
homology with the corresponding appendix of the yeast MetRS
[15,29]. p18 together with MetRS, IleRS, LeuRS and the bifunctional
synthetase GluProRS constitute subcomplex I that is associated
with subcomplex II (p43, ArgRS, GlnRS) of the multi-synthetase
complex via p38, which independently binds to the last two en-
zymes of the complex, LyRS and AspRS [35]. Anchorage of MetRS
onto subcomplex I (and subsequently to the whole complex) de-
pends on the presence of p18 [35], suggesting that p18 interacts
also with a second component of subcomplex I. This could likely
be GluProRS, which also contains a GST-like motif in its N-terminal
appendix [15,29]. Therefore, the Arc1p-MetRS binary interaction
(and probably also the ternary Arc1-MetRS-GluRS complex) in
yeast appears to be replaced in mammals by a p18-MetRS interac-
tion (or an p18-MetRS-GluProRS complex), which in analogy may
occur through the GST-motif containing domains. If such is the
case, the absence of an Arc1p-like TRBD may be compensated by
the tRNA-binding functions of the C-terminal appendix of mamma-
lian MetRS [36] and the repeated units of the linker region of GluP-
roRS [37], all containing the WHEP domain (Fig. 1) [5].
7.2. p38
Human p38 is a 320 amino acid long moderately hydrophobic
protein (Fig. 1), which displays a putative leucine-zipper motif it
its N-terminal part (residues 49–82) [34] and a GST-like motif at
its C-terminus (residues 214–310) [12,29]. Yeast two-hybrid analy-
sis showed that p38 associates withmost of the proteins of themul-
ti-synthetase complex, the stronger interaction partners being p43,
LysRS and AspRS, and hence p38 may function as a core scaffold
protein [34]. A biosensor-based determination of the kinetic
parameters for the interactions between the scaffold p38 protein
and different components of the complex showed very strong bind-
ing to LyRS and AspRS (Kds 0.3 and 4.7 nM, respectively) mediated
by the catalytic core of the enzymes [38]. The leucine-zipper motif
in p38, which forms an amphipathic alpha-helix characteristic of a
coiled-coil structure, mediates its interaction with the
N-terminal part of p43, which also contains two putative leucine-
zipper/coiled-coil motifs (Fig. 1) [39]. Predicted coiled-coil motifs
are also present at the N-terminal appended domains of GlnRS
and ArgRS, which have weak afﬁnity for p38. Truncation studies
have shown that association with GlnRS, ArgRS and p43 involves
the N-terminal part of p38 (residues 1–83) while the rest compo-
nents of the complex bind to its C-terminal part [40]. Therefore,
p38 can connect subcomplexes I and II, which can actually form
in the absence of p38 [35]. The GST-like motifs may mediate asso-
ciation of the p38 C-terminal part with subcomplex I components
p18 and GluProRS, while the coiled-coil motifs may be involved
in the interaction between the p38 N-terminal part and subcom-
plex II components p43, GlnRS and ArgRS. In analogy to the p18-
MetRS-GluProRS assembly, the central core p38-LysRS-AspRS com-
plexmay rely for structure-speciﬁc tRNA binding on the N-terminal
extensions of LysRS and AspRS that display such a function [41,42].
7.3. p43
The N-terminal part of p43, as already mentioned, contains two
putative coiled-coil motifs, and one of themmay be responsible for
its association with the corresponding motif in p38 [39]. The N-ter-
minal domain of p43 also mediates its moderate afﬁnity (Kd = 93
nM) interaction with the N-terminal appended domain of ArgRS
[38,43], which also contains a putative coiled-coil segment
(Fig. 1). In the absence of p43, both ArgRS and GlnRS are removed
from the human multi-synthetase complex [35]. It therefore
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and is responsible for its anchoring to the rest of the complex via
p38, all interactions probably mediated by the coiled-coil domains
present in all four proteins. In an analogous manner to the yeast
Arc1-MetRS-GluRS complex, the TRBD in the C-terminal part of
p43 can serve the structure-speciﬁc tRNA-binding function in the
ternary p43-ArgRS-GlnRS assembly.
8. The biological functions of Arc1p and Arc1p-like proteins
8.1. Affecting aminoacylation activity
From what has been so far reported, it is clear that the functions
of Arc1p and its related proteins have to be connected to two of
their basic molecular properties: their ability to interact with tRNA
and/or to form protein complexes with aminoacyl-tRNA syntheta-
ses. Since aaRSs use tRNA as their substrate, a general tRNA-bind-
ing domain in the vicinity of their catalytic core is expected to
facilitate their activity by increasing the effective local concentra-
tion of their substrate and allowing them to maintain maximal
reactions rates at lower ‘‘nominal” tRNA concentrations. This could
be experimentally observed by a decrease of an aaRS’ km for tRNA
or increase of its apparent afﬁnity when in complex with a protein
carrying a TRBD. On the other hand, speciﬁcity is probably more
important than reaction rate for an aaRS and increased afﬁnity
for any tRNA and not only the cognate one is intuitively destructive
for the accuracy of the aminoacylation reaction. What is the case
with Arc1p?
Early experiments concomitant with the identiﬁcation of Arc1p,
showed that binding of Arc1p to MetRS caused more than 70-fold
reduction in its km for tRNA, a mere ﬁvefold increase in its kcat and
subsequently a higher than 300-fold increase in its catalytic efﬁ-
ciency [7]. This effect required physical association of the synthe-
tase with Arc1p and the presence of the TRBD [14]. Using gel
shift analysis, it was also shown that MetRS could only form a sta-
ble complex with tRNAMet when bound to Arc1p [7,14]. Impor-
tantly, the MetRS-Arc1p complex (unlike Arc1p alone) interacted
speciﬁcally with tRNAMet even in the presence of an excess of a
non-cognate tRNA (e.g. tRNAPhe) [14] or when challenged with a
whole yeast tRNA mixture [11]. The Arc1p-MetRS-GluRS complex,
afﬁnity puriﬁed from yeast cells, contained only the two cognate
tRNAs, which were also able to undergo aminocylation in vitro
and remain bound to the complex [14]. Despite the fact that mono-
meric GluRS bound quite stably to tRNA, association with Arc1p
carrying its TRBD increased both its tRNA binding afﬁnity (by up
to 100-fold) and its aminoacylation activity (by up to 10-fold)
[11,44].
Therefore, the Arc1p-TRBD-mediated stimulation of tRNA afﬁn-
ity and aminoacylation efﬁciency of both its partner synthetases oc-
curs without compromising their speciﬁcities. Moreover, this effect
simply requires the physical proximity of the TRBD to the catalytic
sites and does not appear to involve any major conformational
changes of the enzymes or their substrate tRNAs. The effect also en-
tails unhindered access of both Arc1p and an aaRS to the same tRNA
molecule, that is, their binding sites on tRNA must be distinct. In
support of this, a validated structuralmodel of a complex composed
of Trbp111 (the smallest and more primitive Arc1p homologue),
tRNA and a synthetase indicates that the tRNA is sandwiched be-
tween the two proteins, Trbp111 binding to the outer, convex side
and the synthetase to the inner, concave side of the L-shaped tRNA
molecule [22]. Despite the lack of physical contact between
Trbp111 and the synthetase in this model, a slight but consistent
stimulation of aminoacylation did occur, suggesting that binding
of the TRBD to the tRNA may also to some extent optimize its con-
formation for recognition by the cognate synthetase [22]. A follow-
ing study suggested that Trbp111 acts as a molecular chaperonethat covers and protects or stabilizes the fragile outside corner of
the L-shaped tRNA, a function that may have assisted the selection
and establishment of this structure during the course of early evo-
lution [45]. Acquisition of an additional protein interaction domain
may have then turned Trbp111 into a complex-forming aminoacy-
lation cofactor like Arc1p. Crystal structure information for a TRBD-
tRNA-aaRS complex is certainly and urgently needed to corroborate
all these pieces of data.
The paradigm of Arc1p offers proof-of-principle for the advanta-
geous role of general tRNA-binding domains in tRNA-aminoacyla-
tion. Direct fusions of these domains to the catalytic core of an
aaRS is another course that evolution has followed instead of sim-
ply hooking them up to the enzymes via protein–protein interac-
tions. Examples are the fusion of an Arc1p-like TRBD in plant
[18] and worm [14] MetRS or human TyrRS [14] and the presence
of N-terminal amphiphilic helices or helix-turn-helix (WHEP) do-
mains in several tRNA synthetases (reviewed in [5,6]). In fact, even
the Arc1p TRBD itself can function both in trans (intermolecularly)
or in cis (intramolecularly) at least as far as the aminoacylation
function of MetRS is concerned: artiﬁcial fusion of the TRBD to
the catalytic core of the yeast MetRS was shown to improve its
enzymatic activity and to effectively substitute the MetRS-Arc1p
binary complex in vivo, in terms of yeast growth rate and MetRS
subcellular distribution [46]. Finally, the role of p43 in aminoacyla-
tion is controversial. While an early report suggested that p43 en-
hanced the aminoacylation activity of its partner ArgRS by
reducing its apparent km for tRNA [43], a subsequent study claimed
that the p43 TRBD had no effect to the tRNA binding afﬁnity and
catalytic activity of ArgRS [47]. The possibility still remains that
p43 TRBD acts as a cofactor for another component of the multi-
synthease complex, probably its second partner in subcomplex II,
GlnRS.
8.2. Affecting subcellular distribution and transport of aaRSs and tRNA
An important criterion for the biological signiﬁcance of a pro-
tein’s function is its effect on cell viability and proliferation. In this
respect, Arc1p is not essential for the viability of yeast cells, how-
ever, lack of its expression causes slow growth especially at tem-
peratures higher or lower than those required for optimal
laboratory growth [7]. Similarly, cell growth was reduced when
expression of p18, p38, or p43 was blocked in human cells by sta-
ble small interfering RNA silencing [35]. Disruption of the p38 gene
in mice caused lethality but two days after birth [40]. It, therefore,
appears that the basic life-supporting functions of the cells, includ-
ing tRNA aminoacylation, do not require the presence of Arc1p-like
proteins. Nevertheless, Arc1p can become essential for yeast viabil-
ity when mutations occur in its partner synthetases or in tRNA
exportin Los1p or in nucleoporin Nsp1p [7]. A synthetic lethal mu-
tant carrying a defective MetRS was viable even when only the
N-domain of Arc1p was expressed, suggesting that complex forma-
tion alone could facilitate MetRS function, probably by augmenting
protein stability. In a corresponding mutant with defective GluRS,
the N-domain alone did not sufﬁce but part of the TRBD had to
be additionally present to allow survival demonstrating the
in vivo signiﬁcance of combining complex assembly with tRNA-
binding. In contrast, the synthetic lethal phenotype caused by
mutations in Los1p or Nsp1p could be complemented by the Arc1p
C-domain alone. Peculiarly, a strain completely lacking Los1p was
only viable in the presence of both N and C-domains of Arc1p even
when they were provided as independent, unconnected proteins.
Since the TRBD of Arc1p cannot affect tRNA aminoacylation when
not bound to a synthetase (at least in vitro), these genetic data pro-
vided ﬁrst indications for distinct functions of the Arc1p domains,
not necessarily related to the aminoacylation reaction. This was
further supported by complementation of yeast Arc1p mutants
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Given the genetic interactions of Arc1p, it could be potentially
involved in the transport of tRNA from the nucleus to the cyto-
plasm. Nuclear export of tRNA in yeast involves at least two redun-
dant Los1p-dependent and/or nuclear aminoacylation-dependent
pathways, which may also involve eEF-1A [3,49–53]. Accumulation
of mature tRNA in the nucleus (a phenotype demonstrating a tRNA
nuclear export defect) has not been observed in the absence of
Arc1p, but this may be due to the redundancy of the nuclear export
process. As this redundancy cannot be overcome by depleting
Los1p, because then absence of Arc1p kills the cells, direct involve-
ment of Arc1p as a tRNA transport factor remains an open ques-
tion. However, the genetic data can also be explained by indirect
roles of Arc1p, such as facilitating aminoacylation in the nucleus
(where mature tRNA concentration is normally much lower than
in the cytoplasm), release of the tRNA from its transport factors
at the cytoplasmic side of the nuclear pores or controlling the dis-
tribution of its partner synthetases between nucleus and cyto-
plasm. The latter role has received support from several different
sets of experimental data.
Under wild-type steady state conditions, all three components
of the Arc1p-MetRS-GluRS complex are strictly cytoplasmic and
excluded form the nucleus but their dynamic localization may be
far from simple [12]. Under various conditions that prohibited
complex assembly (because of truncation mutations or absence
of Arc1p) the free components, except of full-length Arc1p, were
also detected inside the nucleus, [12,54]. At least in the case of
MetRS, nuclear localization was also observed upon introduction
of single point mutations that inhibited binding to Arc1p, exclud-
ing the possibility that the ‘‘mislocalizations” were non-speciﬁc ef-
fects of gross misfolding (due to the protein deletions) or general
cell damage (due to the absence of Arc1p) [29]. Although the
free-standing catalytic core of MetRS was found in both cytoplasm
and nucleus, its direct fusion to the TRBD resulted also in nuclear
exclusion [46]. Therefore, exclusive cytoplasmic location could be
achieved by two ways: assembly in the complex (even in the ab-
sence of the TRBD) or association with the TRBD (even in the ab-
sence of a complex).
The presence of GluRS, MetRS and certain mutants of Arc1p in-
side the nucleus (even under non-wild-type conditions) can only
occur, since their large sizes prevent free diffusion through the nu-
clear pores, by nuclear localization signal (NLS)-mediated active
nuclear import. Then the fact that, despite the presence of these
NLSs, the Arc1p-MetRS-GluRS complex remains excluded from
the nucleus must be due to cytoplasmic retention or predominant
nuclear export or masking of the NLSs, possibilities that are not
mutually exclusive. The involvement of nuclear export was shown
at least in the case of free-standing Arc1p. In a yeast strain lacking
the N-terminal domains of both MetRS and GluRS (and making
thus complex assembly with Arc1p impossible), free-standing
Arc1p remained cytoplasmic even when artiﬁcially ﬁtted with a
strong NLS. However, mutation in the major protein exportin
Xpo1/Crm1 caused nuclear accumulation of NLS-Arc1p, suggesting
that Arc1p harbors a strong nuclear export signal (NES) that medi-
ates its efﬁcient nuclear export [54]. Therefore, MetRS and GluRS
that enter the nucleus by their own means can be piggybacked
out of the nucleus by Arc1p, maintaining their concentrations
low in the nucleoplasm and high in the cytoplasm. It is intriguing
to suggest that on its way out of the nucleus, the Arc1p-MetRS-
GluRS complex physically carries with it its cognate tRNAs, thus di-
rectly contributing to efﬁcient export of tRNA to the cytoplasm.
Although regulation of synthetase subcellular distribution by
Arc1p remains mechanistically an incompletely understood pro-
cess, recent data suggest that its principles may also apply in
human cells. Wild-type MetRS localizes exclusively into the cyto-plasm but deletion of its N-terminal protein interaction appendix
(responsible for its anchorage onto the multi-synthetase complex
through p18) allows limited entry into the nucleus [55]. Additional
deletion of its C-terminal general tRNA binding extension increases
substantially its nuclear concentration to levels even higher than
those in the cytoplasm. Therefore, as in yeast, nuclear exclusion
of MetRS involves both protein–protein and protein–tRNA interac-
tions. Accordingly human p43, evenwhen overexpressed, remained
strictly cytoplasmic but deletion of its N-terminal protein interac-
tion domain (that hooks its to p38, GlnRS and ArgRS) caused sub-
stantial nuclear translocation of its TRBD-containing part [24].
Certainly, localization experiments with additional complex-asso-
ciated and free forms of human synthetases are needed in order
to see if this is a general phenomenon or, for some reason, restricted
to the Arc1p/p43-MetRS pair.
The Arc1p-GluRS pair, on the other hand, hides additional sur-
prises. According to a recent breakthrough report, yeast free (i.e.
not Arc1p-bound) cytoplasmic GluRS can also enter the mitochon-
dria, where its acts as a non-discriminating enzyme and charges
tRNAGln with glutamic acid before its transamidation to Gln-
tRNAGln [56]. Although there is some controversy whether transa-
midation is the unique pathway for tRNAGln aminoacylation in
yeast mitochondria [57], the amount of GluRS in the mitochondria
was shown to increase when Arc1p was not expressed [56]. A sim-
ilar effect was also observed when yeast cells were switched from
fermentation to respiratory conditions, which also caused lower
expression of Arc1p [56]. Therefore, it appears that an additional
physiological role of Arc1p can be the sequestration of GluRS in
the cytoplasm as a means to halt mitochondrial protein synthesis
when it is not required (i.e. during fermentation). Although crucial
mechanistic details are still missing, in response to certain signals
Arc1p may thus control the distribution of GluRS between no less
than three subcellular compartments: cytoplasm, nucleoplasm and
the mitochondrial matrix [58].9. Epilogue
Almost 15 years have passed since the identiﬁcation of Arc1p as
a tRNA-binding and aaRS-interacting protein. During this period a
lot of functional and structural information became available for
Arc1p and its homologues in prokaryotes and higher eukaryotes,
which helped demonstrate new principles in the way aaRSs inter-
act with tRNA and with each other. The dynamic nature of these
interactions is attracting new interest and adds a spatio-temporal
component in the basic function of tRNA-aminoacylation that links
it to subcellular protein and tRNA transport processes. What was
before a largely biochemical and structural ﬁeld must now entail
more cell biology in order to understand the greater picture in pro-
tein synthesis by, for example, identifying and characterising the
sorting and transport signals or mechanisms involved. The ancient
Greek philosopher Heraclitus is reported to have said ‘‘TA PANTA
PEI KAI OYDEN MENET” (Ta panta rhei kai ouden menei): ‘‘Everything
ﬂows and nothing stands still” or in a free translation ‘‘everything
moves, everything changes and everything evolves” a concept that
most likely also applies to the world of tRNA, its partner proteins
and the ﬁeld of their study. Rest assured that not everything has
been seen or told about them!
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